Q1 Earnings Estimate for IMAX Issued By Barrington Research

IMAX Co. (NYSE:IMAX) – Analysts at Barrington Research reduced their Q1 2026 EPS estimates for IMAX in a research report issued to clients and investors on Monday, March 24th. Barrington Research analyst P. Sholl now anticipates that the company will post earnings of $0.08 per share for the quarter, down from their previous forecast of $0.11. Barrington Research currently has a “Outperform” rating and a $32.00 price objective on the stock. The consensus estimate for IMAX’s current full-year earnings is $0.91 per share. Barrington Research also issued estimates for IMAX’s FY2026 earnings at $0.89 EPS.

A number of other research analysts have also commented on IMAX. Rosenblatt Securities upped their price objective on IMAX from $28.00 to $35.00 and gave the company a “buy” rating in a report on Thursday, February 20th. Benchmark reaffirmed a “buy” rating and set a $30.00 price target on shares of IMAX in a research report on Thursday, February 20th. StockNews.com upgraded shares of IMAX from a “hold” rating to a “buy” rating in a research note on Wednesday, March 19th. Wells Fargo & Company increased their target price on shares of IMAX from $26.00 to $32.00 and gave the stock an “overweight” rating in a research report on Thursday, February 20th. Finally, Macquarie lifted their price target on shares of IMAX from $28.00 to $30.00 and gave the company an “outperform” rating in a research report on Thursday, February 20th. One investment analyst has rated the stock with a hold rating, nine have assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, IMAX presently has a consensus rating of “Buy” and an average target price of $30.67.

IMAX Trading Up 0.7 %

IMAX stock opened at $27.36 on Wednesday. The company has a market capitalization of $1.45 billion, a price-to-earnings ratio of 55.84, a PEG ratio of 1.49 and a beta of 1.22. The stock’s 50 day moving average is $25.08 and its 200-day moving average is $23.77. IMAX has a 12 month low of $14.94 and a 12 month high of $27.77.

IMAX (NYSE:IMAX) last released its quarterly earnings results on Wednesday, February 19th. The company reported $0.17 earnings per share for the quarter, missing the consensus estimate of $0.31 by ($0.14). The company had revenue of $92.67 million during the quarter, compared to the consensus estimate of $104.08 million. IMAX had a net margin of 7.40% and a return on equity of 8.60%.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in IMAX. Intech Investment Management LLC bought a new position in shares of IMAX in the 3rd quarter valued at $205,000. FMR LLC grew its position in IMAX by 108.4% in the third quarter. FMR LLC now owns 3,949,643 shares of the company’s stock valued at $81,007,000 after acquiring an additional 2,054,031 shares during the last quarter. Quantbot Technologies LP acquired a new position in IMAX during the third quarter worth about $777,000. PEAK6 Investments LLC lifted its holdings in shares of IMAX by 312.1% in the third quarter. PEAK6 Investments LLC now owns 55,676 shares of the company’s stock worth $1,142,000 after acquiring an additional 42,165 shares during the last quarter. Finally, Atom Investors LP acquired a new stake in shares of IMAX in the 3rd quarter valued at approximately $265,000. 93.51% of the stock is currently owned by institutional investors and hedge funds.

IMAX Company Profile

IMAX Corporation, together with its subsidiaries, operates as a technology platform for entertainment and events worldwide. The company operates in two segments, Content Solutions and Technology Products and Services. The company offers IMAX DMR, a proprietary technology that digitally remasters films and other content into IMAX formats for distribution to the IMAX network; IMAX Enhanced that provides end-to-end technology across streaming content and entertainment devices at home; and SSIMWAVE, an AI-driven video quality solutions for media and entertainment companies.